A detailed history of Transcendent Capital Group LLC transactions in Haleon PLC stock. As of the latest transaction made, Transcendent Capital Group LLC holds 368 shares of HLN stock, worth $3,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares
368
Previous 559 34.17%
Holding current value
$3,595
Previous $4.62 Million 15.68%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$8.32 - $10.7 $1,589 - $2,043
-191 Reduced 34.17%
368 $3.89 Million
Q2 2024

Jul 24, 2024

SELL
$8.01 - $8.64 $1,473 - $1,589
-184 Reduced 24.76%
559 $4.62 Million
Q4 2023

Mar 01, 2024

BUY
$7.78 - $8.62 $5,780 - $6,404
743 New
743 $6.12 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Transcendent Capital Group LLC Portfolio

Follow Transcendent Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcendent Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcendent Capital Group LLC with notifications on news.